The plasma membrane: a target and hurdle for the development of anti-Abeta drugs?

Current drug targets. CNS and neurological disorders

Volumn 1, Issue 6, 2002, Pages 567-574

  Talaga, Patrice ^a   Quéré, Luc ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; CELL MEMBRANE; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; METHODOLOGY; PHARMACEUTICS; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELL MEMBRANE; DRUG DELIVERY SYSTEMS; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

MLCS; MLOWN;

EID: 0037794384     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007023338897     Document Type: Review

References (70)